Fundraising FoxTranscera
Boston, US · 7 known investors
Find your way into Transcera
Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases. Its platform combines a lysosome-targeting lipid, a chemical linker, and a peptide or protein binder to degrade soluble and membrane proteins across tissues.
Founders & leadership
Investors · 7
How we know: Portal Innovations's portfolio page · Not right? Tell us
How we know: Tau Ventures's portfolio page · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: board seat on SEC Form D · funding news · Not right? Tell us
How we know: funding news · pear.vc · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcementsSource: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Transcera do?
- Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases. Its platform combines a lysosome-targeting lipid, a chemical linker, and a peptide or protein binder to degrade soluble and membrane proteins across tissues.
- Who founded Transcera?
- Transcera was founded by Wayne Lencer, Hunter Goble, Justin Wolfe.
- Who are Transcera's investors?
- Transcera's investors include Portal Innovations, Tau Ventures, Digitalis Ventures, KdT Ventures, Pear VC, TAU Ventures, Xora Innovation Pte Ltd.
- Where is Transcera headquartered?
- Transcera is headquartered in Boston, US.